These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Are anticoagulants still indicated in pulmonary arterial hypertension? Olschewski H; Rich S Pulm Circ; 2018; 8(4):2045894018807681. PubMed ID: 30284508 [TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis. Caldeira D; Loureiro MJ; Costa J; Pinto FJ; Ferreira JJ Can J Cardiol; 2014 Aug; 30(8):879-87. PubMed ID: 24986048 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation in Pulmonary Arterial Hypertension. Robinson JC; Pugliese SC; Fox DL; Badesch DB Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge. Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973 [TBL] [Abstract][Full Text] [Related]
13. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling. He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615 [No Abstract] [Full Text] [Related]
14. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454 [TBL] [Abstract][Full Text] [Related]
15. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696 [TBL] [Abstract][Full Text] [Related]
16. Coagulation and anticoagulation in pulmonary arterial hypertension. Berger G; Azzam ZS; Hoffman R; Yigla M Isr Med Assoc J; 2009 Jun; 11(6):376-9. PubMed ID: 19697592 [TBL] [Abstract][Full Text] [Related]
17. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil. Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420 [TBL] [Abstract][Full Text] [Related]
18. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273 [TBL] [Abstract][Full Text] [Related]
19. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension. Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886 [TBL] [Abstract][Full Text] [Related]
20. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology. Aktaa S; Gale CP; Brida M; Giannakoulas G; Kovacs G; Adir Y; Benza RL; Böhm M; Coats A; D'Alto M; Escribano-Subias P; Ferrari P; Galiè N; Gibbs JSR; Gin-Sing W; Hoeper MM; Humbert M; Lang IM; Maron BA; Meszaros G; Vonk Noordegraaf A; Price LC; Pepke-Zaba J; Rådegran G; Reis A; Sitbon O; Torbicki A; Ulrich S; Rosenkranz S; Delcroix M Eur J Heart Fail; 2023 Apr; 25(4):469-477. PubMed ID: 36924171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]